Altogether, our results demonstrate that MYC activates the expression of TFs such as SP1, forming a complex that enhances the transcription of SET, and eventually, the expression of CIP2A and SETBP1, resulting in PP2A inactivation and increasing cell proliferation in AML. This evidence concerns the gene SETBP1 and acute myeloid leukemia.